Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

$CRL, $HLF, $IPHI, $PODD, $MSI, $SPTN

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is our list for Monday, 11 May, as follows:

Charles River Laboratories International Inc. (NYSE:CRL) was reiterated as Buy and its price target was raised to 190 from 165 at Citigroup.

Herbalife Nutrition Ltd. (NYSE:HLF) was reiterated as Buy and its price target was raised to 56 from 49 at Citigroup. Shares closed 41.23 Friday after earnings. Shares have a 48.00 consensus price target.

Inphi Corp. (NASDAQ:IPHI) Needham reiterated its Buy rating and raised its price target to 122 from 100.

Insulet Corp. (NASDAQ:PODD) was reiterated as Buy and its target was raised to 250 from 205 at Citigroup. The stock closed up 217.63 + 1.15% and previously had a 190.06 consensus analyst target.

Motorola Solutions Inc. (NYSE:MSI) was maintained with a Buy rating but its price target was cut to 160 from 175 at Citigroup.

SpartanNash Co. (NASDAQ:SPTN) as local grocery stores offer strong earnings in this C-19 coronavirus chaos. Shares closed Friday at 17.92, +10.96%, with a consensus price target of 17.33.

Have a healthy week, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge. Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.